Literature DB >> 14204556

PROGNOSTIC VALUE OF HIGH 10-MINUTE I-131 UPTAKE IN NON-TOXIC GOITRES.

H P HIGGINS, I ELKAN, A DIOSY, T A BAYLEY, G C BUCKLEY.   

Abstract

Forty-two patients with non-toxic goitre and with a high 10-minute uptake of I(131) were treated with 100 mug. of l-triiodothyronine per day for periods up to 36 months. All of the goitres were reduced in size and 10 showed marked regression within one week. Hashimoto's disease was considered an unlikely cause of these goitres because only four of 20 tested had positive antithyroglobulin tests, and these were of low titre (up to 1:81). Chromatographic studies suggested a defect in thyroxine metabolism in many of these patients. It is concluded that a high 10-minute uptake test is useful in predicting a response to therapy and in selecting patients likely to have a detectable defect in thyroxine metabolism.

Entities:  

Keywords:  ADOLESCENCE; ANTIBODIES; CHROMATOGRAPHY; CLINICAL RESEARCH; GERIATRICS; GOITER; IODINE ISOTOPES, DIAGNOSTIC; PROGNOSIS; THYROGLOBULIN; THYROID GLAND FUNCTION TESTS; THYROIDITIS, LYMPHOMATOUS; THYRONINE; THYROXINE

Mesh:

Substances:

Year:  1964        PMID: 14204556      PMCID: PMC1927631     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  4 in total

1.  Regression of goiter by whole thyroid or triiodothyronine.

Authors:  N G SCHNEEBERG; T J STAHL; G MALDIA; H MENDUKE
Journal:  Metabolism       Date:  1962-10       Impact factor: 8.694

2.  Human autoimmune thyroiditis: serological studies.

Authors:  I M ROITT; D DONIACH
Journal:  Lancet       Date:  1958-11-15       Impact factor: 79.321

3.  Treatment of goiter and thyroid nodules with thyroid.

Authors:  E B ASTWOOD; C E CASSIDY; G D AURBACH
Journal:  JAMA       Date:  1960-10-01       Impact factor: 56.272

4.  Use of triiodothyronine for reduction of goiter and detection of thyroid cancer.

Authors:  P STARR; W GOODWIN
Journal:  Metabolism       Date:  1958-07       Impact factor: 8.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.